BiphentinEffects in attention deficit hyperactivity disorder (ADHD) Drivers: a randomised, placebo controlled, crossover study of multilayer-release (MLR) methylphenidate on driving performance in adult ADHD patients.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2010
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms BEAD
- Sponsors Purdue Pharma
- 01 Dec 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 14 Aug 2010 Planned end date (1 Dec 2010) added as reported by ISRCTN: Current Controlled Trials.
- 14 Aug 2010 Status changed from completed to recruiting as reported by ISRCTN: Current Controlled Trials.